Literature DB >> 35355516

Gut microbiome in liver pathophysiology and cholestatic liver disease.

Shengmin Yan1, Xiao-Ming Yin1.   

Abstract

An increasing amount of evidence has shown critical roles of gut microbiome in host pathophysiology. The gut and the liver are anatomically and physiologically connected. Given the critical role of gut-liver axis in the homeostasis of the liver, gut microbiome interplays with a diverse spectrum of hepatic changes, including steatosis, inflammation, fibrosis, cholestasis, and tumorigenesis. In clinic, cholestasis manifests with fatigue, pruritus, and jaundice, caused by the impairment in bile formation or flow. Studies have shown that the gut microbiome is altered in cholestatic liver disease. In this review, we will explore the interaction between the gut microbiome and the liver with a focus on the alteration and the role of gut microbiome in cholestatic liver disease. We will also discuss the prospect of exploiting the gut microbiome in the development of novel therapies for cholestatic liver disease.

Entities:  

Keywords:  Cholestatic liver disease; Gut microbiome; Liver pathophysiology

Year:  2021        PMID: 35355516      PMCID: PMC8963136          DOI: 10.1016/j.livres.2021.08.001

Source DB:  PubMed          Journal:  Liver Res


  151 in total

1.  Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.

Authors:  Na Jiao; Susan S Baker; Adrian Chapa-Rodriguez; Wensheng Liu; Colleen A Nugent; Maria Tsompana; Lucy Mastrandrea; Michael J Buck; Robert D Baker; Robert J Genco; Ruixin Zhu; Lixin Zhu
Journal:  Gut       Date:  2017-08-03       Impact factor: 23.059

Review 2.  The effect of gut microbiota on drug metabolism.

Authors:  Mi Jeong Kang; Hyung Gyun Kim; Jin Sung Kim; Do Gyeong Oh; Yeon Ji Um; Chae Shin Seo; Ji Won Han; Hyun Ji Cho; Ghee Hwan Kim; Tae Cheon Jeong; Hye Gwang Jeong
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-06-12       Impact factor: 4.481

3.  Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.

Authors:  Chi Ma; Miaojun Han; Bernd Heinrich; Qiong Fu; Qianfei Zhang; Milan Sandhu; David Agdashian; Masaki Terabe; Jay A Berzofsky; Valerie Fako; Thomas Ritz; Thomas Longerich; Casey M Theriot; John A McCulloch; Soumen Roy; Wuxing Yuan; Vishal Thovarai; Shurjo K Sen; Mathuros Ruchirawat; Firouzeh Korangy; Xin Wei Wang; Giorgio Trinchieri; Tim F Greten
Journal:  Science       Date:  2018-05-25       Impact factor: 47.728

4.  Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.

Authors:  Jasmohan S Bajaj; Genta Kakiyama; Tor Savidge; Hajime Takei; Zain A Kassam; Andrew Fagan; Edith A Gavis; William M Pandak; Hiroshi Nittono; Phillip B Hylemon; Prapaporn Boonma; Anthony Haag; Douglas M Heuman; Michael Fuchs; Binu John; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2018-09-20       Impact factor: 17.425

5.  Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease.

Authors:  Christoph Grander; Timon E Adolph; Verena Wieser; Patrick Lowe; Laura Wrzosek; Benedek Gyongyosi; Doyle V Ward; Felix Grabherr; Romana R Gerner; Alexandra Pfister; Barbara Enrich; Dragos Ciocan; Sophie Macheiner; Lisa Mayr; Matthias Drach; Patrizia Moser; Alexander R Moschen; Gabriel Perlemuter; Gyongyi Szabo; Anne Marie Cassard; Herbert Tilg
Journal:  Gut       Date:  2017-05-26       Impact factor: 23.059

6.  Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Authors:  Dana Tedesco; Manoj Thapa; Chui Yoke Chin; Yong Ge; Minghao Gong; Jing Li; Sanjeev Gumber; Patrick Speck; Elizabeth J Elrod; Eileen M Burd; William H Kitchens; Joseph F Magliocca; Andrew B Adams; David S Weiss; Mansour Mohamadzadeh; Arash Grakoui
Journal:  Gastroenterology       Date:  2018-02-15       Impact factor: 22.682

Review 7.  Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents.

Authors:  Jens Walter; Anissa M Armet; B Brett Finlay; Fergus Shanahan
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

8.  Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.

Authors:  Malte Rühlemann; Timur Liwinski; Femke-Anouska Heinsen; Corinna Bang; Roman Zenouzi; Martin Kummen; Louise Thingholm; Marie Tempel; Wolfgang Lieb; Tom Karlsen; Ansgar Lohse; Johannes Hov; Gerald Denk; Frank Lammert; Marcin Krawczyk; Christoph Schramm; Andre Franke
Journal:  Aliment Pharmacol Ther       Date:  2019-06-28       Impact factor: 8.171

9.  Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.

Authors:  Martin Kummen; Louise B Thingholm; Malte C Rühlemann; Kristian Holm; Simen H Hansen; Lucas Moitinho-Silva; Timur Liwinski; Roman Zenouzi; Christopher Storm-Larsen; Øyvind Midttun; Adrian McCann; Per M Ueland; Marte L Høivik; Mette Vesterhus; Marius Trøseid; Matthias Laudes; Wolfgang Lieb; Tom H Karlsen; Corinna Bang; Christoph Schramm; Andre Franke; Johannes R Hov
Journal:  Gastroenterology       Date:  2020-12-31       Impact factor: 22.682

10.  The gut microbiota is associated with immune cell dynamics in humans.

Authors:  Jonas Schluter; Jonathan U Peled; Bradford P Taylor; Kate A Markey; Melody Smith; Ying Taur; Rene Niehus; Anna Staffas; Anqi Dai; Emily Fontana; Luigi A Amoretti; Roberta J Wright; Sejal Morjaria; Maly Fenelus; Melissa S Pessin; Nelson J Chao; Meagan Lew; Lauren Bohannon; Amy Bush; Anthony D Sung; Tobias M Hohl; Miguel-Angel Perales; Marcel R M van den Brink; Joao B Xavier
Journal:  Nature       Date:  2020-11-25       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.